Comments

ANVS

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.52

NaN%

After Hours: 5:50 PM EDT

15 minutes delayed

(ANVS) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

(ANVS) Stock Quotes, Forecast and News Summary

ANVS stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	- / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange
RSI	42
Short Interest	18.42%
Days to Cover	1

Recent News

Immutep Up as Combo Therapy Meets Carcinoma Study Goals

Immutep Limited (NASDAQ: IMMP) jumped 14.9% after it announced positive results from cohort B of the late-stage TACTI-003 (KEYNOTE-PNC-34) study.

Zacks

Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

UniQure Soars on New Huntington's Disease Study Data

uniQure N.V. (NASDAQ: QURE) surged 76.5% on Jul 9 after it announced updated interim data, including up to 24 months of follow-up data, from 29 treated patients enrolled in the ongoing early to mid-stage studies of AMT-130 for Huntington's disease in the United States and EU.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.